Mayo Clinic researchers are investigating:
- Urine-based marker tests for detecting urothelial cancer of the ureter, bladder and kidneys. Urine-based marker tests are generally noninvasive and potentially reliable for detecting low-grade urothelial cancer. The tests identify key urine indicators that suggest cancer recurrence.
- Drugs for treating advanced urothelial cancer.
- Experimental treatments for urothelial cancer.
- New tissue-based markers for detecting and managing urothelial cancer.
See a list of publications by Mayo doctors on urothelial cancer on PubMed, a service of the National Library of Medicine.